- 1Department of Geriatric Psychiatry, Wenzhou Seventh People's Hospital, Wenzhou, Zhejiang, China
- 2Department of Psychosomatic Medicine, Wenzhou Seventh People's Hospital, Wenzhou, Zhejiang, China
Objective: To evaluate the effectiveness of a tripartite biopsychosocial intervention program on mental health and quality of life in elderly patients with depression secondary to geriatric diseases.
Methods: A cluster randomized controlled trial was conducted with 166 elderly patients between January 2022 and January 2025. Wards were randomized into an intervention group (n = 83) and a control group (n = 83). The intervention group received a biopsychosocial integrated program, while the control group received standard psychiatric care. Assessments were conducted at baseline and 1, 2, and 3 months post-intervention using the Hamilton Rating Scale for Depression (HAMD-17), Profile of Mood States (POMS), Five Facet Mindfulness Questionnaire (FFMQ), Mental Health Continuum-Short Form (MHC-SF), and the Generic Quality of Life Inventory-74 (GQOLI-74). Patient satisfaction was evaluated at 3 months.
Results: The intervention group showed significantly greater improvement in depressive symptoms (Finteraction = 29.003, p < 0.001), with a higher response rate (98.75% vs. 90.24%, p < 0.05). Mental health scores (POMS, FFMQ, MHC-SF) improved more in the intervention group (Finteraction = 143.577, 11.155, 14.658; p < 0.001). At 3 months, GQOLI-74 scores and patient satisfaction were also significantly higher (p < 0.05).
Conclusion: The biopsychosocial intervention significantly improves depression, mental health, and quality of life in elderly patients with geriatric disease-related depression.
1 Introduction
The accelerating global population aging has led to a rising prevalence of geriatric diseases, with depression secondary to age-related chronic conditions emerging as a critical public health challenge impacting elderly well-being (Arnaud et al., 2022; Cavdar et al., 2024). According to the World Health Organization (WHO), approximately 14% of adults aged 60 years and older are living with a mental disorder, with depression being among the most common conditions. Mental disorders in this age group account for more than 10% of total disability-adjusted life years (DALYs), highlighting the heavy global burden (Petrovic and Gaggioli, 2020). Furthermore, nearly 80% of adults aged 65 years and above live with at least one chronic condition, and about 50% have two or more, substantially increasing the risk of comorbid depression (Khan et al., 2022). A recent meta-analysis estimated the global prevalence of major depression in the elderly at 13.3% (95% CI: 8.4–20.3%), with slightly higher rates in women (11.9%) than men (9.7%) (Abdoli et al., 2022). Another meta-analysis focusing on older adults with chronic diseases reported even higher rates, with pooled prevalence reaching over 60% in hospitalized or primary-care elderly patients (Ahmed et al., 2024). These findings underscore that depression secondary to chronic illness is not only frequent but also exerts profound impacts on functional status, rehabilitation outcomes, and quality of life. Importantly, recent studies emphasize a bidirectional relationship between depression and chronic diseases in older adults. Depression may arise as a consequence of conditions such as cardiovascular disease, diabetes, and stroke, while also worsening disease progression, reducing treatment adherence, and increasing mortality. Conversely, chronic diseases markedly elevate the risk of depression, creating a vicious cycle that impairs recovery and quality of life (Werneck and Stubbs, 2024; Zhou et al., 2024). This reciprocal link highlights the need for integrated approaches addressing both physical and psychological health.
Depression secondary to geriatric diseases refers to depressive states induced by prolonged illness, declining physical function, and compromised self-care capacity in elderly patients (Kupisz-Urbańska et al., 2024). These patients often become trapped in a vicious cycle of “disease-depression-functional deterioration” through the interaction between physical comorbidities and psychological disturbances, exhibiting significantly poorer mental health and quality of life compared to the general elderly population. Traditional biomedical approaches focus predominantly on symptom relief through pharmacological treatment, which may be insufficient for elderly patients who often face multiple comorbidities, functional decline, and psychosocial stressors such as loneliness, reduced social participation, and caregiver burden (Ma and Strelow, 2025). In contrast, a biopsychosocial model provides a more comprehensive framework by simultaneously addressing biological vulnerabilities, psychological distress, and social determinants of health.
Developing an integrated trinity therapeutic model addressing somatic, psychological, and social dimensions holds substantial significance for improving holistic health in patients with depression secondary to geriatric diseases. This trinity therapeutic framework, grounded in the biopsychosocial medical model, integrates multidisciplinary resources to establish a coordinated intervention system, potentially offering novel solutions for enhancing patient outcomes. Recent studies have demonstrated the promise of integrative interventions, including multidisciplinary collaboration, cognitive behavioral therapy (CBT) combined with social support, though systematic empirical research specifically evaluating biopsychosocial trinity interventions for elderly populations remains scarce (Jalali et al., 2024). In addition, prior studies have shown that mindfulness-based programs can effectively reduce depressive symptoms and improve cognitive function in older adults, while structured social engagement activities have been linked to better psychological well-being and reduced loneliness (Demarzo et al., 2015; Han, 2022). Multidisciplinary interventions—integrating medical management with psychosocial support—have also demonstrated improved treatment adherence and quality of life in geriatric populations (Werner et al., 2022). These findings support the rationale for incorporating mindfulness, social participation, and team-based care into a biopsychosocial framework for elderly patients with depression.
Breaking from traditional unidimensional medical paradigms, this study proposes a multidimensional intervention framework tailored for elderly patients under the biopsychosocial model. While previous work has acknowledged the value of integrated care, most interventions in older adults have remained limited to single domains—such as pharmacological management, stand-alone psychological therapies, or community-based activities—implemented in isolation rather than as a coordinated system. The originality of the present research lies in advancing beyond these fragmented approaches by developing a comprehensive, systematically structured program that integrates medical, psychological, and social components within one cohesive framework. Specifically, medical management in our study is dynamically tailored through both pharmacological adjustment and exercise-based rehabilitation; psychological support incorporates mindfulness practices and narrative-based life review to strengthen coping capacity; and social engagement is reinforced through intergenerational activities and structured family workshops to enhance support networks. By embedding these elements into a unified biopsychosocial model, our study provides a scalable, evidence-based approach tailored to the complex needs of elderly patients with depression secondary to chronic diseases. Through comparative analysis of mental health and functional improvements among 166 patients suffering from depression secondary to geriatric diseases, we investigate the efficacy of this trinity therapeutic model in enhancing psychological well-being and quality of life, aiming to provide evidence-based insights for optimizing comprehensive care strategies in geriatric depression management.
2 Methods
2.1 Participants
A cluster randomized controlled trial was conducted involving 166 elderly patients diagnosed with depression secondary to geriatric diseases, admitted to our hospital between January 2022 and January 2025. Participants were allocated at the ward level, with Ward A (83 patients) assigned to the intervention group and Ward B (83 patients) to the control group using a computer-generated randomization sequence via SPSS 26.0. This design ensured balanced baseline characteristics and sample sizes between groups.
Sample size estimation was performed based on the 17-item Hamilton Rating Scale for Depression (HAMD-17) as the primary outcome. Assuming a minimal clinically important difference of 3–5 points in HAMD-17 scores between groups (Cohen’s d ≈ 0.5), with α = 0.05 (two-tailed), β = 0.20 (80% power), and an effect size d = 0.5, PASS software calculated a required sample of 64 patients per group. Accounting for a cluster randomization design with an intraclass correlation coefficient of 0.02 and a design effect of 1.18, the adjusted sample size was 128 × 1.18 ≈ 151. After including a 10% attrition buffer, the final sample comprised 166 participants.
Eligibility criteria included: (1) meeting the International Classification of Diseases, 10th Revision (ICD-10) diagnostic criteria for depression; (2) age ≥ 60 years; (3) baseline HAMD-17 score ≥ 14 (indicating mild depression or above); (4) Mini-Mental State Examination (MMSE) score ≥ 24; and (5) ability to comply with interventions and provision of informed consent by patients or guardians. Exclusion criteria comprised: (1) history of schizophrenia, bipolar disorder, severe personality disorders, active suicidal ideation, or psychotic symptoms; (2) recent antipsychotic medication, electroconvulsive therapy, or experimental antidepressant treatments within 3 months; (3) severe neurological disorders (e.g., Alzheimer’s disease, vascular dementia, brain tumors); (4) organ failure with life expectancy < 6 months; or (5) alcohol or substance abuse. Attritional criteria included (1) voluntary withdrawal by participants or termination of intervention at the request of legal guardians, or (2) loss to follow-up (defined as missing two consecutive assessments or intervention sessions). During the study, 3 participants in the intervention group and 1 in the control group withdrew, resulting in 80 and 82 completers, respectively. Baseline characteristics are summarized in Table 1. The study protocol was approved by the Ethics Committee of Wenzhou Seventh People’s Hospital (approval number: EC-20210826-23).
2.2 Tests administered
All assessments were independently conducted by two psychiatric attending physicians (≥ 5 years of clinical experience) blinded to group allocation. Prior to evaluation, assessors underwent consistency training to achieve an intraclass correlation coefficient (ICC) > 0.85. Case report forms anonymized group assignments using coded identifiers, and discrepancies were resolved by a third senior physician.
① HAMD-17 score. HAMD-17 scores were assessed at baseline, 1, 2, and 3 months post-intervention. This scale comprises 17 items (total score range: 0–52), with severity categorized as follows: 0–7 (no depression), 8–13 (mild depression), 14–18 (moderate depression), and ≥ 19 (severe depression) (Hassanzadeh et al., 2024).
② Clinical efficacy. At 3 months, clinical response was classified based on HAMD-17 score changes: marked improvement (≥ 50% reduction), partial improvement (20–49% reduction), or no improvement (< 20% reduction or worsening). Total response rate was calculated as (marked + partial improvements)/total participants × 100%.
③ Mental health indicators. Mental health status was evaluated using the Profile of Mood States (POMS) (López-Jiménez et al., 2021), Five Facet Mindfulness Questionnaire (FFMQ) (Shallcross et al., 2020), and Mental Health Continuum-Short Form (MHC-SF) (Plouffe et al., 2022) at baseline, 1, 2, and 3 months post-intervention. The POMS assesses seven mood domains across 40 items (total score: 0–200; lower scores indicate better mood). The FFMQ measures five mindfulness facets, including observing, describing, acting with awareness, non-judging, and non-reactivity (score range: 39–195; higher scores reflect stronger mindfulness). The MHC-SF evaluates emotional, psychological, and social well-being (score range: 14–70; higher scores denote better mental health).
④ Quality of life assessment. The Generic Quality of Life Inventory-74 (GQOLI-74) (Gao et al., 2023) was administered at baseline and 3 months after intervention, assessing four domains (physical function, psychological function, social function, and material life status), each standardized to 0–100 (higher scores indicate superior quality of life).
⑤ Satisfaction evaluation. A self-designed 5-point Likert-scale questionnaire (Cronbach’s α = 0.82) assessed 3-month post-intervention satisfaction across three dimensions: program utility (1–5), provider professionalism (1–5), and overall satisfaction (1–5). Total scores were categorized as very satisfied (13–15), satisfied (10–12), neutral (6–9), or dissatisfied (< 6).
2.3 Procedures
Both groups received interventions for 3 months.
2.3.1 Control group
The control group received standard psychiatric care, which involved physician-led management following clinical guidelines for geriatric disease treatment, including routine medication prescriptions based on diagnostic results. At diagnosis, healthcare providers informed caregivers about the confirmed disease entity, clinical status, and necessary precautionary measures. Monthly mental health lectures were conducted for all patients, covering topics such as common psychological symptoms and coping strategies. Post-discharge, monthly outpatient follow-ups included blood pressure and glucose monitoring. Medication dosages were adjusted if patients reported changes in somatic symptoms.
2.3.2 Intervention group
The intervention group underwent a tripartite biopsychosocial intervention program.
1. Team composition and role allocation. A multidisciplinary team was established, comprising a medical subgroup (geriatricians, rehabilitation therapists, and nurses), a psychological subgroup (psychologists and social workers), and a social support subgroup (family coordinators and community staff). Real-time team communication was facilitated through a dedicated WeChat group with separate channels for medical, psychological, and social support. Weekly meetings were held every Wednesday to review patient progress and coordinate tasks.
2. Standardized intervention. ① Biological module: Geriatricians conducted biweekly face-to-face follow-ups to adjust pharmacotherapy based on vital signs (blood pressure, glucose, and lipid levels). Rehabilitation therapists designed tailored Baduanjin exercise plans, delivered in three 45-min supervised group sessions weekly at the rehabilitation center of our hospital. Patients were assigned daily home exercises (15–20 min of stretching or walking) monitored via smart wristbands, with data synchronized to APP for remote supervision and adjustment. Nurses distributed simplified cognitive behavioral therapy for insomnia (CBT-I) manuals, comprising sleep hygiene education, stimulus control therapy, and sleep restriction therapy, accompanied by standardized implementation protocols. Psychologists conducted weekly video consultations for sleep regulation guidance. ② Psychological module: Psychologists conducted two weekly 60-min group sessions involving mindfulness-based breathing, body scanning, and meditation. Patients completed daily 15-min APP-guided mindfulness exercises with audio prompts and progress tracking. Monthly 90-min group activities encouraged life review and shared reflections on significant experiences. ③ Social module: Community workers organized monthly intergenerational social activities (e.g., craft workshops, storytelling sessions) and facilitated patient engagement in volunteer roles (e.g., library assistance, plant maintenance) based on individual interests. Weekly 60-min family workshops educated caregivers about depression secondary to geriatric diseases, communication strategies, and home care techniques.
3. Quality control. Intervention adherence was monitored via the APP, requiring ≥ 70% completion of psychological exercises (based on literature-defined thresholds for therapeutic efficacy) (Yao et al., 2025). Initial non-compliance triggered automated reminders and phone follow-ups, and persistent non-compliance (≥ 2 consecutive weeks) prompted supplemental interventions (family supervision or task simplification). Exercise intensity was regulated using a heart rate threshold [(220 − age) × 0.6]. Patients with a ≥ 5-point increase in HAMD-17 scores during intervention were referred for further evaluation. Team performance and protocol effectiveness were reviewed monthly, with iterative adjustments to optimize outcomes. The core framework of the tripartite biopsychosocial intervention is illustrated in Figure 1.
2.4 Statistical procedures
All data were analyzed using SPSS version 22.0. Categorical variables, including clinical efficacy, overall satisfaction, and gender, were expressed as frequencies (percentages) and analyzed using chi-square tests. Continuous variables conforming to a normal distribution were presented as mean ± standard deviation ( ). Between-group comparisons at individual time points were performed using independent samples t-tests, while longitudinal changes across multiple time points were assessed via repeated-measures analysis of variance (ANOVA). Figures were generated using SPSS 22.0 and GraphPad Prism 8. A p-value < 0.05 was considered statistically significant.
3 Results
3.1 Comparison of HAMD-17 scores
No significant differences in baseline HAMD-17 scores were observed between the intervention and control groups (p > 0.05). Longitudinal analysis revealed a statistically significant interaction effect of group and time (Finteraction = 29.003, p < 0.001), with the intervention group demonstrating superior improvement in depressive symptoms compared to the control group across all follow-up time points (1, 2, and 3 months; p < 0.05 for all between-group comparisons). Detailed scores at each assessment interval are presented in Table 2. The trajectory of HAMD-17 score changes over time is illustrated in Figure 2.
3.2 Comparison of clinical efficacy
The intervention group demonstrated a significantly higher total response rate of 98.75% compared to 90.24% in the control group, with a statistically significant difference observed between groups (p = 0.043). Detailed efficacy outcomes are summarized in Table 3.
3.3 Comparison of mental health outcomes
Baseline scores for POMS, FFMQ, and MHC-SF showed no significant differences between groups (p > 0.05). Longitudinal analyses revealed significant group × time interaction effects for all mental health indicators (POMS: Finteraction = 143.577; FFMQ: Finteraction = 11.155; MHC-SF: Finteraction = 14.658; p < 0.001 for all), with the intervention group demonstrating superior improvements compared to the control group at each follow-up interval (1, 2, and 3 months; p < 0.05 for all between-group comparisons). Detailed score trajectories and intergroup differences are presented in Table 4.
3.4 Comparison of GQOL-74 scores
No significant differences in baseline GQOLI-74 domain scores were observed between the intervention and control groups (p > 0.05). At the 3-month follow-up, the intervention group exhibited significantly greater improvements across all domains of the GQOLI-74 compared to the control group (all p < 0.001), with psychological function demonstrating the most pronounced enhancement (t = 13.106, p < 0.001). Domain-specific score trajectories and intergroup differences are detailed in Table 5.
3.5 Comparison of patient satisfaction
The intervention group demonstrated significantly higher overall satisfaction than the control group (Z = −3.141, p = 0.002), with 62.50% of intervened participants reporting “very satisfied” compared to 39.02% in the control group. Categorical distributions of satisfaction ratings across both groups are detailed in Table 6, while Figure 3 visually summarizes these contrasts.
4 Discussion
The accelerating global aging population has precipitated a surge in geriatric diseases, with depression secondary to these conditions emerging as a critical public health challenge (Pijnenburg et al., 2024; Kovacheva et al., 2025). Naguy and Al-Khadhari (2024) Estimate that approximately 40% of elderly patients with chronic illnesses experience comorbid depressive symptoms. Miletic et al. (2025) have further emphasized that depressive symptoms profoundly impede rehabilitation outcomes in elderly patients, compromising their self-care capacity and diminishing social engagement. Conventional biomedical approaches, predominantly focused on somatic symptom management, often neglect the psychosocial dimensions of care, thereby failing to address the multifaceted health needs of this vulnerable population. Therefore, developing effective interventions holds significant implications for improving mental health and quality of life in elderly patients with secondary depression. In this context, the tripartite biopsychosocial intervention program developed in this study represents a paradigm shift, innovatively synergizing somatic, psychological, and social interventions to holistically alleviate depressive symptoms and enhance overall quality of life in elderly patients with depression secondary to geriatric diseases, suggesting promising applicability in geriatric mental health management.
At the level of somatic intervention, the program achieved precise and systematic management of physical symptoms through dynamic medication adjustment, Baduanjin training, and sleep management. Patients in the intervention group showed a reduction in HAMD-17 scores over three months, significantly more obvious than the decrease in the control group. This may be attributed to the program’s multidimensional somatic intervention. Regular Baduanjin training improves neuroplasticity by promoting the secretion of brain-derived neurotrophic factor (BDNF), and real-time monitoring of exercise data via smart bracelets increases patient compliance, effectively regulating the hypothalamic–pituitary–adrenal (HPA) axis and reducing cortisol levels, which aligns with emerging evidence on exercise-induced neuroplasticity. For instance, Zhao et al. (2024) demonstrated that mind–body exercises like Baduanjin enhance HPA axis regulation and promote neurotrophic factor secretion, which are critical for mood stabilization. Combined with CBT-I and sleep monitoring, sleep efficiency in the intervention group improved significantly, further alleviating depressive symptoms. Similarly, a meta-analysis by Marinelli et al. (2024) highlighted the additive benefits of combining physical activity with psychological interventions. Moreover, it has been demonstrated that regular exercise regimens can not only enhance physical conditioning but also optimize sleep architecture, thereby facilitating improved engagement in daily activities and elevating quality of life within the physical functional domain (Hossain et al., 2024). In contrast to conventional care relying solely on medication adjustment, the program’s collaboration among geriatricians, rehabilitation therapists, and nurses enables dynamic tracking of physical indicators such as blood pressure and blood glucose. For example, heart rate variability monitoring was used to adjust antihypertensive medication for patients with hypertension, highlighting the advantages of multidisciplinary cooperation in somatic management.
Psychological improvement potentially stems from the deep integration of mindfulness training and cognitive restructuring. The intervention group significantly enhanced mindfulness levels (remarkably increased FFMQ scores), mood states (significantly reduced POMS scores), and psychological well-being (obviously enhanced MHc-sF scores) through twice-weekly group mindfulness sessions, daily APP-guided practices, and monthly life review activities. The core mechanisms may be as follows: mindfulness meditation enhances prefrontal cortex regulation of the amygdala, reducing excessive responses to negative emotions (Kral et al., 2018). Van der Velden et al. (2023) have also shown that a clinically effective mindfulness intervention modulates neurocognitive functioning during depressive rumination and the ability to sustain attention to the body. As a form of narrative therapy, life review helps patients reconstruct self-worth, consistent with the significant improvement in psychological function. In line with a mixed method study by Kwan et al. (2019), the nurse-led short-term life-review intervention significantly enhanced spiritual well-being, with participants endorsing the intervention as both acceptable and clinically meaningful. Compared with traditional individual psychotherapy, the program’s gamified APP design (e.g., point rewards, progress tracking) boosts mindfulness practice compliance, demonstrating how technology enhances the accessibility and sustainability of psychological intervention.
As for social function, its enhancement relies on the dual construction of community resource integration and family support systems. Through monthly intergenerational activities (e.g., intergenerational handicraft making), personalized community volunteer services (e.g., library organization, plant care), and weekly family workshops, the intervention group’s social function score increased, significantly higher than the control group. The underlying mechanisms may be related to that community activities enhance social engagement through “intergenerational reciprocity,” increasing weekly social interaction and reducing loneliness. Family workshops improve caregivers’ empathy and communication skills, and reduce family conflicts, creating a more supportive family environment. Our findings resonate with Liu et al. (2024) assertion that robust social support networks buffer against anxiety and depression in older adults, while Li et al. (2024) emphasized the role of community continuity in sustaining mental health gains. In contrast to the “fragmented” support of single mental health lectures in conventional care, the program’s precise intervention by community workers, through “needs assessment-resource matching,” customizes social participation plans for patients (e.g., assisting painting-talented patients in community art gallery volunteering), increasing social function recovery rates. This demonstrates the unique advantages of the “hospital-community-family” linkage model in social support.
Compared with traditional interventions, the core innovation of our program lies in breaking through single-discipline limitations. Through real-time communication among medical, psychological, and social support teams (e.g., specialized WeChat groups, weekly meetings) and technology empowerment (smart device data synchronization, APP intervention quality control), it achieves integrated intervention from somatic symptom control to comprehensive psychological and social function rehabilitation. This study showed that the intervention group’s total effective rate was 98.75%, significantly higher than 90.24% in the control group, with the improvement in psychological and social functions far exceeding conventional care. This synergistic effect of “precise somatic management-deep psychological intervention-extensive social support” not only relieves depressive symptoms but also enhances overall quality of life through multiple pathways of neural remodeling, cognitive restructuring, and social capital reconstruction, providing a scalable practice paradigm for the comprehensive intervention of depression secondary to geriatric diseases.
Despite these promising results, several limitations warrant consideration. First, the single-center design and moderate sample size may constrain the generalizability of findings. Second, the 3-month intervention period precludes assessment of long-term efficacy, particularly regarding relapse prevention. Third, while the biopsychosocial model demonstrated superiority over conventional care, the relative contributions of individual intervention components (e.g., Baduanjin vs. mindfulness training) remain to be disentangled. Future multicenter trials with extended follow-up periods and factorial designs are needed to optimize intervention protocols and validate scalability.
5 Conclusion
This cluster randomized controlled trial provides robust empirical support for the biopsychosocial integrated intervention as a transformative approach to managing depression secondary to geriatric diseases. By concurrently addressing biological vulnerabilities, cognitive-emotional distortions, and social determinants of health, this model transcends the reductionist limitations of traditional care paradigms. As global healthcare systems grapple with the complexities of aging populations, such integrative frameworks offer a viable pathway to enhancing both clinical outcomes and patient-centered care quality.
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
Ethics statement
This study was approved by the Human Ethics Committee of Wenzhou Seventh People's Hospital (approval number: EC-20210826-23). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
YC: Methodology, Investigation, Data curation, Supervision, Validation, Conceptualization, Writing – review & editing, Resources, Formal analysis, Writing – original draft, Funding acquisition. XL: Software, Validation, Conceptualization, Resources, Data curation, Visualization, Formal analysis, Writing – original draft, Methodology. XY: Investigation, Formal analysis, Writing – review & editing, Visualization, Methodology, Data curation, Project administration, Conceptualization, Funding acquisition.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This research was supported by Wenzhou Science and Technology Bureau—Wenzhou Basic Research Project (project number: Y20210536).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Gen AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Abdoli, N., Salari, N., Darvishi, N., Jafarpour, S., Solaymani, M., Mohammadi, M., et al. (2022). The global prevalence of major depressive disorder (MDD) among the elderly: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 132, 1067–1073. doi: 10.1016/j.neubiorev.2021.10.041
Ahmed, H., Khaled, H., Allam, A. A., Alodini, B., Azzam, A., Hjazeen, A. A., et al. (2024). Depression in geriatrics: a systematic review and meta-analysis of prevalence and risk factors in Egypt. BMC Geriatr. 24:930. doi: 10.1186/s12877-024-05484-2
Arnaud, A. M., Brister, T. S., Duckworth, K., Foxworth, P., Fulwider, T., Suthoff, E. D., et al. (2022). Impact of major depressive disorder on comorbidities: a systematic literature review. J. Clin. Psychiatry 83:21r14328. doi: 10.4088/JCP.21r14328
Cavdar, V. C., Ballica, B., Aric, M., Karaca, Z. B., Altunoglu, E. G., and Akbas, F. (2024). Exploring depression, comorbidities and quality of life in geriatric patients: a study utilizing the geriatric depression scale and WHOQOL-OLD questionnaire. BMC Geriatr. 24:687. doi: 10.1186/s12877-024-05264-y
Demarzo, M. M., Montero-Marin, J., Cuijpers, P., Zabaleta-del-Olmo, E., Mahtani, K. R., Vellinga, A., et al. (2015). The efficacy of mindfulness-based interventions in primary care: a meta-analytic review. Ann. Fam. Med. 13, 573–582. doi: 10.1370/afm.1863
Gao, N., Li, Y., Sang, C., He, J., and Chen, C. (2023). Effect of high-quality nursing on neurological function, psychological moods, and quality of life of elderly patients with stroke. Front Neurol. 14:1259737. doi: 10.3389/fneur.2023.1259737
Han, A. (2022). Mindfulness-based interventions for older adults with dementia or mild cognitive impairment: a Meta-analysis. Clin. Gerontol. 45, 763–776. doi: 10.1080/07317115.2021.1995561
Hassanzadeh, E., Moradi, G., Arasteh, M., and Moradi, Y. (2024). The effect of repetitive transcranial magnetic stimulation on the Hamilton depression rating Scale-17 criterion in patients with major depressive disorder without psychotic features: a systematic review and meta-analysis of intervention studies. BMC Psychol. 12:480. doi: 10.1186/s40359-024-01981-6
Hossain, M. N., Lee, J., Choi, H., Kwak, Y. S., and Kim, J. (2024). The impact of exercise on depression: how moving makes your brain and body feel better. Phys Act Nutr. 28, 43–51. doi: 10.20463/pan.2024.0015
Jalali, A., Ziapour, A., Karimi, Z., Rezaei, M., Emami, B., Kalhori, R. P., et al. (2024). Global prevalence of depression, anxiety, and stress in the elderly population: a systematic review and meta-analysis. BMC Geriatr. 24:809. doi: 10.1186/s12877-024-05311-8
Khan, M. R., Malik, M. A., Akhtar, S. N., Yadav, S., and Patel, R. (2022). Multimorbidity and its associated risk factors among older adults in India. BMC Public Health 22:746. doi: 10.1186/s12889-022-13181-1
Kovacheva, K., de la Fe Rodríguez-Muñoz, M., Gómez-Baya, D., Domínguez-Salas, S., and Motrico, E. (2025). Relationship between social support and perinatal depression during the COVID-19 pandemic. J. Reprod. Infant Psychol. 43, 167–180. doi: 10.1080/02646838.2023.2230585
Kral, T. R. A., Schuyler, B. S., Mumford, J. A., Rosenkranz, M. A., Lutz, A., and Davidson, R. J. (2018). Impact of short- and long-term mindfulness meditation training on amygdala reactivity to emotional stimuli. NeuroImage 181, 301–313. doi: 10.1016/j.neuroimage.2018.07.013
Kupisz-Urbańska, M., Religioni, U., Niegowska, W., Szydlik, J., Czapski, P., Sinnadurai, S., et al. (2024). The relation between parameters of physical performance and depression in consecutive hospitalized geriatric patients with heart failure. Nutrients 16:3392. doi: 10.3390/nu16193392
Kwan, C. W. M., Chan, C. W. H., and Choi, K. C. (2019). The effectiveness of a nurse-led short term life review intervention in enhancing the spiritual and psychological well-being of people receiving palliative care: a mixed method study. Int. J. Nurs. Stud. 91, 134–143. doi: 10.1016/j.ijnurstu.2018.12.007
Li, X., He, Y., Chen, S., and Zhang, J. (2024). The impact of community services usage on geriatric depression: a ten-year follow-up study. BMC Geriatr. 24:723. doi: 10.1186/s12877-024-05290-w
Liu, Y., Yang, M., Zhao, Y., Wang, Z., He, J., Wang, Y., et al. (2024). Social support mediates social frailty with anxiety and depression. BMC Pulm. Med. 24:390. doi: 10.1186/s12890-024-03202-7
López-Jiménez, C. M., Cano-García, F. J., Sanduvete-Chaves, S., and Chacón-Moscoso, S. (2021). Profile of mood states factor structure does not accurately account for patients with chronic pain. Pain Med. 22, 2604–2614. doi: 10.1093/pm/pnab127
Ma, C., and Strelow, B. (2025). Recognition and management of treatment-resistant depression. JAAPA 38, 20–26. doi: 10.1097/01.Jaa.0000000000000163
Marinelli, R., Parker, A. G., Levinger, I., Bourke, M., Patten, R., and Woessner, M. N. (2024). Resistance training and combined resistance and aerobic training as a treatment of depression and anxiety symptoms in young people: a systematic review and meta-analysis. Early Interv. Psychiatry 18, 585–598. doi: 10.1111/eip.13528
Miletic, B., Plisic, A., Jelovica, L., Saner, J., Hesse, M., Segulja, S., et al. (2025). Depression and its effect on geriatric rehabilitation outcomes in Switzerland's aging population. Medicina (Kaunas) 61:257. doi: 10.3390/medicina61020257
Naguy, A., and Al-Khadhari, S. (2024). Geriatric depression: what clinicians need to know. Prim. Care Companion CNS Disord. 26:23lr03686. doi: 10.4088/PCC.23lr03686
Petrovic, M., and Gaggioli, A. (2020). Digital mental health tools for caregivers of older adults-a scoping review. Front. Public Health 8:128. doi: 10.3389/fpubh.2020.00128
Pijnenburg, L. J., Velikonja, T., Pietrzak, R. H., DePierro, J., de Haan, L., Todd, A. C., et al. (2024). Perceived social support and longitudinal trajectories of depression and anxiety in world trade center responders. Soc. Psychiatry Psychiatr. Epidemiol. 59, 1413–1424. doi: 10.1007/s00127-023-02569-y
Plouffe, R. A., Liu, A., Richardson, J. D., and Nazarov, A. (2022). Validation of the mental health continuum: short form among Canadian Armed Forces personnel. Health Rep. 33, 3–12. doi: 10.25318/82-003-x202200500001-eng
Shallcross, A., Lu, N. Y., and Hays, R. D. (2020). Evaluation of the psychometric properties of the five facet of mindfulness questionnaire. J. Psychopathol. Behav. Assess. 42, 271–280. doi: 10.1007/s10862-019-09776-5
Van der Velden, A. M., Scholl, J., Elmholdt, E. M., Fjorback, L. O., Harmer, C. J., Lazar, S. W., et al. (2023). Mindfulness training changes brain dynamics during depressive rumination: a randomized controlled trial. Biol. Psychiatry 93, 233–242. doi: 10.1016/j.biopsych.2022.06.038
Werneck, A. O., and Stubbs, B. (2024). Bidirectional relationship between chronic pain and depressive symptoms in middle-aged and older adults. Gen. Hosp. Psychiatry 89, 49–54. doi: 10.1016/j.genhosppsych.2024.05.007
Werner, C., Wolf-Belala, N., Nerz, C., Abel, B., Braun, T., Gruneberg, C., et al. (2022). A multifactorial interdisciplinary intervention to prevent functional and mobility decline for more participation in (pre-)frail community-dwelling older adults (PromeTheus): study protocol for a multicenter randomized controlled trial. BMC Geriatr. 22:124. doi: 10.1186/s12877-022-02783-4
Yao, J., Zou, Y., Luo, Q., Luo, Y., Chunghon, T., and Shang, H. (2025). Social support and depression mediate the relationship between childhood trauma and nonsuicidal self-injury. Clin. Psychol. Psychother. 32:e70030. doi: 10.1002/cpp.70030
Zhao, Y. L., Sun, S. Y., Qin, H. C., Zhu, Y. L., Luo, Z. W., Qian, Y., et al. (2024). Research progress on the mechanism of exercise against depression. World J. Psychiatry 14, 1611–1617. doi: 10.5498/wjp.v14.i11.1611
Keywords: geriatric disease, secondary depression, trinity of physical, psychological, and social functions, mental health, quality of life
Citation: Chen Y, Lin X and Ye X (2025) A tripartite biopsychosocial intervention program enhances mental health and quality of life in elderly patients with depression secondary to geriatric diseases. Front. Psychol. 16:1696674. doi: 10.3389/fpsyg.2025.1696674
Edited by:
Anna Maria Berardi, Université de Lorraine, FranceReviewed by:
Devi Das, Indian Council of Medical Research (ICMR), IndiaArchana Singh, Amity University, Noida, India
Copyright © 2025 Chen, Lin and Ye. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yan Chen, Y3kxMzU4NzY2MDI1OEAxNjMuY29t